Advancing Life Sciences Through AI Innovation in the Life Sciences Domain

The life sciences industry is under growing structural pressure to accelerate time to market and offset the rising patent cliff, making digital R&D acceleration through AI and analytics essential to pipeline competitiveness. Advances in genomic science, together with regulatory acceptance of real-world evidence, are propelling the shift toward precision medicine and reshaping patient outcomes. At the same time, escalating payor cost containment, tighter government price controls, and complex reimbursement pathways are intensifying market access challenges, pushing companies to adopt digital engagement and omnichannel strategies. Rising modality complexity and supply chain volatility are driving demand for resilient, digitally enabled manufacturing powered by smart factories and predictive analytics. Global Capability Centers are also evolving from cost-arbitrage models into hubs of capability and innovation-led value creation, serving as engines of digital execution and transformation. To navigate these shifts, enterprises increasingly collaborate with service providers, leveraging specialized digital expertise to accelerate change across the value chain.

Both demand-side and supply-side trends are covered in our Life Sciences Digital Services 2026 Market Insights™ and Life Sciences Digital Services 2026 RadarView™, respectively. These reports present a comprehensive study of digital service providers in the life sciences industry, including top trends, analysis, and recommendations. It takes a close look at the leaders, innovators, disruptors, challenge, and tech pioneers in this market.

We evaluated 43 service providers across and future proofing. Of the 43 providers, we recognized 27 that brought the most value to the market over the past 12 months.

The reports recognize service providers across four categories:

• • Leaders: Accenture, Capgemini, Cognizant, HCLTech, Infosys, TCS, and Wipro
  • Innovators: Genpact, IBM, LTIMindtree, Tech Mahindra, and Hitachi Digital Services
  • Disruptors: Atos, Birlasoft, Indegene, NTT DATA, UST, Virtusa, and Zensar
  • Challengers: Coforge, DXC, Happiest Minds, and Persistent Systems
  • Tech Pioneers: IQVIA, Merative, Salesforce, and Veeva

Figure 1 below from the full report illustrates these categories:

“Accelerating time-to-market, advancing precision medicine, and rising market-access pressures are reshaping life sciences. As modality complexity and supply chain volatility increase, digitally enabled manufacturing and Global Capability Centers are becoming critical drivers of innovation and growth.” said Rakesh Patro, Avasant Partner.

The reports provide several findings, including the following:

• • Life sciences enterprises are deploying AI/ML for target identification, molecule design, trial simulation, and protocol optimization, alongside cloud-based clinical data platforms and digital twins.
  • Life sciences organizations are deploying cloud-based genomic and diagnostics platforms that unify R&D, companion diagnostics, and real-world evidence, enabling biomarker-driven trials and precision patient segmentation.
  • Escalating payor cost-containment measures, tighter government price controls, and growing market access complexity are creating sustained pressure.
  • Organizations are embracing digitally enabled, resilient, and scalable operations, leveraging advanced automation, AI-driven supply chain visibility, and predictive analytics to mitigate volatility, optimize production flows, and enhance responsiveness across global networks.
  • GCCs are evolving from cost-focused hubs to strategic centers of innovation and capability-led value creation.

“AI is reshaping life sciences as enterprises use AI/ML, advanced analytics, and digital platforms to accelerate drug discovery, optimize trials, enable precision medicine, modernize pricing and market access, and build resilient, smart manufacturing and GCC-led innovation models,” said Eratha Poongkuntran, associate director at Avasant.

The RadarView also features detailed profiles of 27 service providers, along with their solutions, offerings, and experience in assisting life sciences enterprises in their digital transformation journeys.

This Research Byte provides a brief overview of Avasant’s Life Sciences Digital Services 2026 Market Insights™ and Life Sciences Digital Services 2026 RadarView™. (Click for pricing.)